nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimantadine—Gastrointestinal symptom NOS—Sorafenib—thyroid cancer	0.0377	0.0377	CcSEcCtD
Rimantadine—Cardiac failure—Vandetanib—thyroid cancer	0.0245	0.0245	CcSEcCtD
Rimantadine—Dysphagia—Vandetanib—thyroid cancer	0.0206	0.0206	CcSEcCtD
Rimantadine—Bronchospasm—Vandetanib—thyroid cancer	0.0203	0.0203	CcSEcCtD
Rimantadine—Pollakiuria—Vandetanib—thyroid cancer	0.0191	0.0191	CcSEcCtD
Rimantadine—Depression—Vandetanib—thyroid cancer	0.0183	0.0183	CcSEcCtD
Rimantadine—Stomatitis—Vandetanib—thyroid cancer	0.0179	0.0179	CcSEcCtD
Rimantadine—Cardiac failure—Sorafenib—thyroid cancer	0.0165	0.0165	CcSEcCtD
Rimantadine—Dysphagia—Sorafenib—thyroid cancer	0.0139	0.0139	CcSEcCtD
Rimantadine—Tremor—Vandetanib—thyroid cancer	0.0135	0.0135	CcSEcCtD
Rimantadine—Parosmia—Epirubicin—thyroid cancer	0.0126	0.0126	CcSEcCtD
Rimantadine—Loss of consciousness—Vandetanib—thyroid cancer	0.0126	0.0126	CcSEcCtD
Rimantadine—Cough—Vandetanib—thyroid cancer	0.0125	0.0125	CcSEcCtD
Rimantadine—Convulsion—Vandetanib—thyroid cancer	0.0125	0.0125	CcSEcCtD
Rimantadine—Hypertension—Vandetanib—thyroid cancer	0.0124	0.0124	CcSEcCtD
Rimantadine—Anxiety—Vandetanib—thyroid cancer	0.0122	0.0122	CcSEcCtD
Rimantadine—Stomatitis—Sorafenib—thyroid cancer	0.0121	0.0121	CcSEcCtD
Rimantadine—Dry mouth—Vandetanib—thyroid cancer	0.012	0.012	CcSEcCtD
Rimantadine—Parosmia—Doxorubicin—thyroid cancer	0.0117	0.0117	CcSEcCtD
Rimantadine—Insomnia—Vandetanib—thyroid cancer	0.0106	0.0106	CcSEcCtD
Rimantadine—Dyspnoea—Vandetanib—thyroid cancer	0.0105	0.0105	CcSEcCtD
Rimantadine—Tinnitus—Sorafenib—thyroid cancer	0.0104	0.0104	CcSEcCtD
Rimantadine—Dyspepsia—Vandetanib—thyroid cancer	0.0103	0.0103	CcSEcCtD
Rimantadine—Decreased appetite—Vandetanib—thyroid cancer	0.0102	0.0102	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.0101	0.0101	CcSEcCtD
Rimantadine—Ageusia—Epirubicin—thyroid cancer	0.0101	0.0101	CcSEcCtD
Rimantadine—Fatigue—Vandetanib—thyroid cancer	0.0101	0.0101	CcSEcCtD
Rimantadine—Rigors—Epirubicin—thyroid cancer	0.01	0.01	CcSEcCtD
Rimantadine—Constipation—Vandetanib—thyroid cancer	0.01	0.01	CcSEcCtD
Rimantadine—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00959	0.00959	CcSEcCtD
Rimantadine—Ageusia—Doxorubicin—thyroid cancer	0.00936	0.00936	CcSEcCtD
Rimantadine—Rigors—Doxorubicin—thyroid cancer	0.00929	0.00929	CcSEcCtD
Rimantadine—Abdominal pain—Vandetanib—thyroid cancer	0.00927	0.00927	CcSEcCtD
Rimantadine—Lacrimation increased—Epirubicin—thyroid cancer	0.00889	0.00889	CcSEcCtD
Rimantadine—Syncope—Sorafenib—thyroid cancer	0.0087	0.0087	CcSEcCtD
Rimantadine—Loss of consciousness—Sorafenib—thyroid cancer	0.00852	0.00852	CcSEcCtD
Rimantadine—Cough—Sorafenib—thyroid cancer	0.00846	0.00846	CcSEcCtD
Rimantadine—Atrioventricular block—Epirubicin—thyroid cancer	0.00845	0.00845	CcSEcCtD
Rimantadine—Asthenia—Vandetanib—thyroid cancer	0.00842	0.00842	CcSEcCtD
Rimantadine—Gait disturbance—Epirubicin—thyroid cancer	0.0084	0.0084	CcSEcCtD
Rimantadine—Hypertension—Sorafenib—thyroid cancer	0.00837	0.00837	CcSEcCtD
Rimantadine—Lacrimation increased—Doxorubicin—thyroid cancer	0.00823	0.00823	CcSEcCtD
Rimantadine—Dry mouth—Sorafenib—thyroid cancer	0.00807	0.00807	CcSEcCtD
Rimantadine—Diarrhoea—Vandetanib—thyroid cancer	0.00803	0.00803	CcSEcCtD
Rimantadine—Atrioventricular block—Doxorubicin—thyroid cancer	0.00782	0.00782	CcSEcCtD
Rimantadine—Shock—Sorafenib—thyroid cancer	0.00779	0.00779	CcSEcCtD
Rimantadine—Gait disturbance—Doxorubicin—thyroid cancer	0.00777	0.00777	CcSEcCtD
Rimantadine—Dizziness—Vandetanib—thyroid cancer	0.00776	0.00776	CcSEcCtD
Rimantadine—Anorexia—Sorafenib—thyroid cancer	0.00754	0.00754	CcSEcCtD
Rimantadine—Vomiting—Vandetanib—thyroid cancer	0.00746	0.00746	CcSEcCtD
Rimantadine—Rash—Vandetanib—thyroid cancer	0.0074	0.0074	CcSEcCtD
Rimantadine—Dermatitis—Vandetanib—thyroid cancer	0.00739	0.00739	CcSEcCtD
Rimantadine—Headache—Vandetanib—thyroid cancer	0.00735	0.00735	CcSEcCtD
Rimantadine—Mental disability—Epirubicin—thyroid cancer	0.00711	0.00711	CcSEcCtD
Rimantadine—Dyspnoea—Sorafenib—thyroid cancer	0.00705	0.00705	CcSEcCtD
Rimantadine—Nausea—Vandetanib—thyroid cancer	0.00697	0.00697	CcSEcCtD
Rimantadine—Dyspepsia—Sorafenib—thyroid cancer	0.00697	0.00697	CcSEcCtD
Rimantadine—Decreased appetite—Sorafenib—thyroid cancer	0.00688	0.00688	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00683	0.00683	CcSEcCtD
Rimantadine—Fatigue—Sorafenib—thyroid cancer	0.00682	0.00682	CcSEcCtD
Rimantadine—Constipation—Sorafenib—thyroid cancer	0.00677	0.00677	CcSEcCtD
Rimantadine—Eye pain—Epirubicin—thyroid cancer	0.00659	0.00659	CcSEcCtD
Rimantadine—Mental disability—Doxorubicin—thyroid cancer	0.00658	0.00658	CcSEcCtD
Rimantadine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00647	0.00647	CcSEcCtD
Rimantadine—Abdominal pain—Sorafenib—thyroid cancer	0.00626	0.00626	CcSEcCtD
Rimantadine—Eye pain—Doxorubicin—thyroid cancer	0.0061	0.0061	CcSEcCtD
Rimantadine—Cardiac failure—Epirubicin—thyroid cancer	0.0061	0.0061	CcSEcCtD
Rimantadine—Asthenia—Sorafenib—thyroid cancer	0.00568	0.00568	CcSEcCtD
Rimantadine—Cardiac failure—Doxorubicin—thyroid cancer	0.00564	0.00564	CcSEcCtD
Rimantadine—Ataxia—Epirubicin—thyroid cancer	0.00559	0.00559	CcSEcCtD
Rimantadine—Diarrhoea—Sorafenib—thyroid cancer	0.00541	0.00541	CcSEcCtD
Rimantadine—Dizziness—Sorafenib—thyroid cancer	0.00523	0.00523	CcSEcCtD
Rimantadine—Ataxia—Doxorubicin—thyroid cancer	0.00518	0.00518	CcSEcCtD
Rimantadine—Dysphagia—Epirubicin—thyroid cancer	0.00514	0.00514	CcSEcCtD
Rimantadine—Vomiting—Sorafenib—thyroid cancer	0.00503	0.00503	CcSEcCtD
Rimantadine—Rash—Sorafenib—thyroid cancer	0.00499	0.00499	CcSEcCtD
Rimantadine—Dermatitis—Sorafenib—thyroid cancer	0.00498	0.00498	CcSEcCtD
Rimantadine—Headache—Sorafenib—thyroid cancer	0.00496	0.00496	CcSEcCtD
Rimantadine—Dysphagia—Doxorubicin—thyroid cancer	0.00476	0.00476	CcSEcCtD
Rimantadine—Pollakiuria—Epirubicin—thyroid cancer	0.00475	0.00475	CcSEcCtD
Rimantadine—Nausea—Sorafenib—thyroid cancer	0.0047	0.0047	CcSEcCtD
Rimantadine—Stomatitis—Epirubicin—thyroid cancer	0.00447	0.00447	CcSEcCtD
Rimantadine—Pollakiuria—Doxorubicin—thyroid cancer	0.0044	0.0044	CcSEcCtD
Rimantadine—Stomatitis—Doxorubicin—thyroid cancer	0.00414	0.00414	CcSEcCtD
Rimantadine—Hypoaesthesia—Epirubicin—thyroid cancer	0.0041	0.0041	CcSEcCtD
Rimantadine—Oedema peripheral—Epirubicin—thyroid cancer	0.00406	0.00406	CcSEcCtD
Rimantadine—Tinnitus—Epirubicin—thyroid cancer	0.00384	0.00384	CcSEcCtD
Rimantadine—Hypoaesthesia—Doxorubicin—thyroid cancer	0.00379	0.00379	CcSEcCtD
Rimantadine—Oedema peripheral—Doxorubicin—thyroid cancer	0.00375	0.00375	CcSEcCtD
Rimantadine—Chills—Epirubicin—thyroid cancer	0.00369	0.00369	CcSEcCtD
Rimantadine—Tinnitus—Doxorubicin—thyroid cancer	0.00355	0.00355	CcSEcCtD
Rimantadine—Tension—Epirubicin—thyroid cancer	0.00352	0.00352	CcSEcCtD
Rimantadine—Nervousness—Epirubicin—thyroid cancer	0.00348	0.00348	CcSEcCtD
Rimantadine—Chills—Doxorubicin—thyroid cancer	0.00342	0.00342	CcSEcCtD
Rimantadine—Agitation—Epirubicin—thyroid cancer	0.00329	0.00329	CcSEcCtD
Rimantadine—Tension—Doxorubicin—thyroid cancer	0.00325	0.00325	CcSEcCtD
Rimantadine—Nervousness—Doxorubicin—thyroid cancer	0.00322	0.00322	CcSEcCtD
Rimantadine—Syncope—Epirubicin—thyroid cancer	0.00321	0.00321	CcSEcCtD
Rimantadine—Palpitations—Epirubicin—thyroid cancer	0.00317	0.00317	CcSEcCtD
Rimantadine—Loss of consciousness—Epirubicin—thyroid cancer	0.00315	0.00315	CcSEcCtD
Rimantadine—Cough—Epirubicin—thyroid cancer	0.00313	0.00313	CcSEcCtD
Rimantadine—Convulsion—Epirubicin—thyroid cancer	0.0031	0.0031	CcSEcCtD
Rimantadine—Hypertension—Epirubicin—thyroid cancer	0.00309	0.00309	CcSEcCtD
Rimantadine—Agitation—Doxorubicin—thyroid cancer	0.00305	0.00305	CcSEcCtD
Rimantadine—Anxiety—Epirubicin—thyroid cancer	0.00304	0.00304	CcSEcCtD
Rimantadine—Dry mouth—Epirubicin—thyroid cancer	0.00298	0.00298	CcSEcCtD
Rimantadine—Syncope—Doxorubicin—thyroid cancer	0.00297	0.00297	CcSEcCtD
Rimantadine—Confusional state—Epirubicin—thyroid cancer	0.00295	0.00295	CcSEcCtD
Rimantadine—Palpitations—Doxorubicin—thyroid cancer	0.00293	0.00293	CcSEcCtD
Rimantadine—Loss of consciousness—Doxorubicin—thyroid cancer	0.00291	0.00291	CcSEcCtD
Rimantadine—Cough—Doxorubicin—thyroid cancer	0.00289	0.00289	CcSEcCtD
Rimantadine—Shock—Epirubicin—thyroid cancer	0.00288	0.00288	CcSEcCtD
Rimantadine—Convulsion—Doxorubicin—thyroid cancer	0.00287	0.00287	CcSEcCtD
Rimantadine—Hypertension—Doxorubicin—thyroid cancer	0.00286	0.00286	CcSEcCtD
Rimantadine—Tachycardia—Epirubicin—thyroid cancer	0.00285	0.00285	CcSEcCtD
Rimantadine—Hyperhidrosis—Epirubicin—thyroid cancer	0.00283	0.00283	CcSEcCtD
Rimantadine—Anxiety—Doxorubicin—thyroid cancer	0.00281	0.00281	CcSEcCtD
Rimantadine—Anorexia—Epirubicin—thyroid cancer	0.00279	0.00279	CcSEcCtD
Rimantadine—Dry mouth—Doxorubicin—thyroid cancer	0.00276	0.00276	CcSEcCtD
Rimantadine—Confusional state—Doxorubicin—thyroid cancer	0.00273	0.00273	CcSEcCtD
Rimantadine—Shock—Doxorubicin—thyroid cancer	0.00266	0.00266	CcSEcCtD
Rimantadine—Insomnia—Epirubicin—thyroid cancer	0.00265	0.00265	CcSEcCtD
Rimantadine—Tachycardia—Doxorubicin—thyroid cancer	0.00264	0.00264	CcSEcCtD
Rimantadine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00262	0.00262	CcSEcCtD
Rimantadine—Dyspnoea—Epirubicin—thyroid cancer	0.00261	0.00261	CcSEcCtD
Rimantadine—Somnolence—Epirubicin—thyroid cancer	0.0026	0.0026	CcSEcCtD
Rimantadine—Anorexia—Doxorubicin—thyroid cancer	0.00258	0.00258	CcSEcCtD
Rimantadine—Dyspepsia—Epirubicin—thyroid cancer	0.00257	0.00257	CcSEcCtD
Rimantadine—Decreased appetite—Epirubicin—thyroid cancer	0.00254	0.00254	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00252	0.00252	CcSEcCtD
Rimantadine—Fatigue—Epirubicin—thyroid cancer	0.00252	0.00252	CcSEcCtD
Rimantadine—Constipation—Epirubicin—thyroid cancer	0.0025	0.0025	CcSEcCtD
Rimantadine—Insomnia—Doxorubicin—thyroid cancer	0.00245	0.00245	CcSEcCtD
Rimantadine—Dyspnoea—Doxorubicin—thyroid cancer	0.00241	0.00241	CcSEcCtD
Rimantadine—Feeling abnormal—Epirubicin—thyroid cancer	0.00241	0.00241	CcSEcCtD
Rimantadine—Somnolence—Doxorubicin—thyroid cancer	0.00241	0.00241	CcSEcCtD
Rimantadine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00239	0.00239	CcSEcCtD
Rimantadine—Dyspepsia—Doxorubicin—thyroid cancer	0.00238	0.00238	CcSEcCtD
Rimantadine—Decreased appetite—Doxorubicin—thyroid cancer	0.00235	0.00235	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00234	0.00234	CcSEcCtD
Rimantadine—Fatigue—Doxorubicin—thyroid cancer	0.00233	0.00233	CcSEcCtD
Rimantadine—Constipation—Doxorubicin—thyroid cancer	0.00231	0.00231	CcSEcCtD
Rimantadine—Abdominal pain—Epirubicin—thyroid cancer	0.00231	0.00231	CcSEcCtD
Rimantadine—Feeling abnormal—Doxorubicin—thyroid cancer	0.00223	0.00223	CcSEcCtD
Rimantadine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00221	0.00221	CcSEcCtD
Rimantadine—Abdominal pain—Doxorubicin—thyroid cancer	0.00214	0.00214	CcSEcCtD
Rimantadine—Asthenia—Epirubicin—thyroid cancer	0.0021	0.0021	CcSEcCtD
Rimantadine—Diarrhoea—Epirubicin—thyroid cancer	0.002	0.002	CcSEcCtD
Rimantadine—Asthenia—Doxorubicin—thyroid cancer	0.00194	0.00194	CcSEcCtD
Rimantadine—Dizziness—Epirubicin—thyroid cancer	0.00193	0.00193	CcSEcCtD
Rimantadine—Vomiting—Epirubicin—thyroid cancer	0.00186	0.00186	CcSEcCtD
Rimantadine—Diarrhoea—Doxorubicin—thyroid cancer	0.00185	0.00185	CcSEcCtD
Rimantadine—Rash—Epirubicin—thyroid cancer	0.00184	0.00184	CcSEcCtD
Rimantadine—Dermatitis—Epirubicin—thyroid cancer	0.00184	0.00184	CcSEcCtD
Rimantadine—Headache—Epirubicin—thyroid cancer	0.00183	0.00183	CcSEcCtD
Rimantadine—Dizziness—Doxorubicin—thyroid cancer	0.00179	0.00179	CcSEcCtD
Rimantadine—Nausea—Epirubicin—thyroid cancer	0.00174	0.00174	CcSEcCtD
Rimantadine—Vomiting—Doxorubicin—thyroid cancer	0.00172	0.00172	CcSEcCtD
Rimantadine—Rash—Doxorubicin—thyroid cancer	0.00171	0.00171	CcSEcCtD
Rimantadine—Dermatitis—Doxorubicin—thyroid cancer	0.0017	0.0017	CcSEcCtD
Rimantadine—Headache—Doxorubicin—thyroid cancer	0.0017	0.0017	CcSEcCtD
Rimantadine—Nausea—Doxorubicin—thyroid cancer	0.00161	0.00161	CcSEcCtD
